We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

ICER Says No to Molnupiravir, Yes to Paxlovid and Fluvoxamine for Outpatient COVID Treatment

May 16, 2022
Merck’s oral COVID treatment molnupiravir lacks adequate evidence to support claims that it’s any more effective than symptomatic care. Read More

NIH Shares COVID-19 Technologies With Medicines Patent Pool

May 16, 2022
The technologies are also made available through the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) program. Read More

South Africa Manufacturer Plans to Stop Making COVID-19 Vaccines

May 16, 2022
The plant has produced more than 200 million doses of COVID-19 vaccines. Read More

FDA Encourages Veru to Submit EUA Application for COVID-19 Therapy

May 13, 2022
In the wake of strongly positive data and an FDA go-ahead, Veru will seek an Emergency Use Authorization (EUA) for sabizabulin, its investigational COVID-19 therapy. Read More

Moderna Completes EUA Submission for Use of COVID-19 Vaccine in Children

May 13, 2022
Spikevax is not currently authorized or approved for children under 18. Read More

Emergent Hid Quality Problems With COVID-19 Vaccines, New Report Shows

May 12, 2022
The troubled manufacturing plant Emergent BioSolutions concealed proof of quality problems at its Baltimore, Md., location just a month and a half before it told the FDA that 15 million COVID-19 vaccine doses manufactured there had been contaminated. Read More

FDA Provides Update on Mesa Biotech’s Recall of Its Accula COVID-19 Tests

May 12, 2022
False positive results could lead to further exposure of uninfected individuals to the SARS-CoV-2 virus, the agency said. Read More

UK Study Shows Promising Data for Fourth COVID-19 Vaccine Shot

May 11, 2022
The UK currently permits people over age 75 and people who are immunosuppressed to get the fourth COVID-19 vaccine shot. Read More

FDA Open to Less Than 50 Percent Efficacy in COVID Vaccines for Smallest Kids

May 10, 2022
In a May 6 briefing before Congress, the director of the FDA’s Center of Biologics Evaluation and Research (CBER), Peter Marks, said the agency would not withhold authorization for a pediatric vaccine solely because it did not reach a 50 percent efficacy threshold at blocking symptomatic infection — a requirement that had been previously listed in FDA guidance. Read More

French Regulatory Agency to File Criminal Charges Against Didier Raoult-Led Institute

May 10, 2022
Raoult denied the gravity of the IHU’s practices. Read More

Rhinostics’ Automated Nasal Swab for COVID-19 Testing Approved by Health Canada

May 10, 2022
The swabs work with a variety of automated decappers to create hands-free workflows. Read More

Recall of Skippack Medical’s Unapproved COVID-19 Test Designated Class 1 by FDA

May 10, 2022
No false positive or negative test results were reported, the company said. Read More
Previous 1 2 3 4 5 6 7 8 9 … 164 165 Next

Upcoming Events

  • 17May

    CDER’s Priorities for 2022: What You Must Know About New Guidance and Program Plans

  • 18May

    FDA’s New Distributor Licensing Standards: What Manufacturers, Wholesale Distributors and Third-Party Logistics Providers Must Know

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 21Jun

    Medical Device Reporting: Best Practices and Common Pitfalls

  • 22Jun

    Meet CDRH’s New Strategic Priorities: Where the Center is Headed and How Devicemakers Can Keep Up

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • FDA Grants 510(k) Clearance to iSono Health's Atusa Wearable 3D Breast Ultrasound

  • FDA Approves Mitsubishi Tanabe Oral Form of Radicava for ALS

  • Philips Gains FDA’s 510(k) Clearance for Its MR 7700 Diagnostic System

  • Sanofi Ordered to Pay More Than $400,000 to Family Over Depakine Side Effects

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing